|
gptkbp:instanceOf
|
gptkb:veterinary_medicine
analgesic
opioid
|
|
gptkbp:antidote
|
gptkb:diprenorphine
|
|
gptkbp:ATCCode
|
N02AC90
|
|
gptkbp:brand
|
gptkb:M99
gptkb:Immobilon
|
|
gptkbp:CASNumber
|
14521-96-1
|
|
gptkbp:chemicalFormula
|
C19H23NO3
|
|
gptkbp:compatibleWith
|
human medicine (except in rare cases)
|
|
gptkbp:controlledSubstanceSchedule
|
yes
|
|
gptkbp:discoveredBy
|
gptkb:M._L._Friend
|
|
gptkbp:discoveredIn
|
1963
|
|
gptkbp:effect
|
potent opioid agonist
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
etorphine
|
|
gptkbp:IUPACName
|
gptkb:(5α,6β)-17-(cyclopropylmethyl)-7,8-didehydro-4,5-epoxymorphinan-3,6-diol
|
|
gptkbp:legalStatus
|
gptkb:Schedule_I_(US)
gptkb:Class_A_(UK)
|
|
gptkbp:molecularWeight
|
313.39 g/mol
|
|
gptkbp:PubChem_CID
|
CHEMBL1201207
5360515
4515036
|
|
gptkbp:relatedTo
|
gptkb:morphine
gptkb:buprenorphine
|
|
gptkbp:routeOfAdministration
|
injection
|
|
gptkbp:sideEffect
|
respiratory depression
|
|
gptkbp:toxicity
|
extremely high in humans
|
|
gptkbp:UNII
|
6K3WJA5Z6O
|
|
gptkbp:usedFor
|
immobilization of large animals
|
|
gptkbp:bfsParent
|
gptkb:Thebaine
|
|
gptkbp:bfsLayer
|
6
|